Cagrilintide × empower-peptides.com — lab test, June 2025
freedomdiagnosticstesting.com publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
This certificate carries no lookup code.
Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 5 mg · Lab measured 4.95 mg
99% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 1.2 mg using the measured mass, against 1.3 mg on the label — 1% less.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
Independent HPLC purity analysis of Cagrilintide from empower-peptides.com, performed by freedomdiagnosticstesting.com on June 19, 2025. Reported purity: 99.78%. Net content: 4.95 mg against 5 mg labeled (99% of label). Batch EMP-CAGR-250528-A5. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Other lots of Cagrilintide from empower-peptides.com
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| EMP-CAGR-250716-B10ZZ | 24 Jul 2025 | freedomdiagnosticstesting.com | 99.13% | 94% | Unverified |
| EMP-CAGR-250716-B5 | 24 Jul 2025 | freedomdiagnosticstesting.com | 99.46% | 79% | Unverified |
| EMP-CARGI-250528-A10 | 19 Jun 2025 | freedomdiagnosticstesting.com | 99.84% | 100% | Unverified |
| EMP-CAGRI-GLP1-250528-A10 | 17 Jun 2025 | freedomdiagnosticstesting.com | 99.82% | 75% | Unverified |
| EMP-CAGR-250528-A5 | 19 Jun 2023 | freedomdiagnosticstesting.com | 99.78% | 99% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion